LIVE WebinarTuesday, June 7, 20223:00 – 4:30 PM Eastern Time Register NowExtracellular DNA in blood has actually emerged as a minimally invasive biomarker for finding illness. Apart from sequencing cell-free DNA pieces, scientists can likewise obtain details about methylation states and expression patterns. Researchers combine these information to understand the pathogenic procedures that result in DNA shedding and to establish biomarkers that can predict diseases prior to patients establish signs. In this webinar brought to you by The Scientist, Stella Goulopoulou and Iwijn de Vlaminck will go over how they examine cell-free DNA to determine biomarkers of different illness and their complications.Topics to be coveredCirculating mitochondrial DNA characteristics in preeclampsiaCell-free biomarkers to predict immune-related issues of COVID-19, organ transplants, and stem cell therapiesRegister NowMeet the Speakers: Styliani (Stella) Goulopoulou, PhDAssociate Professor of PhysiologyPhysiology DivisionLawrence D. Longo, MD Center for Perinatal BiologyLoma Linda University, Loma Linda, CaliforniaIwijn De Vlaminck, PhDAssociate ProfessorNancy E. and Peter C. Meinig School of BiomedicalEngineeringCornell UniversitySponsored by.
